BARBIERI, VITTORIO
 Distribuzione geografica
Continente #
NA - Nord America 360
EU - Europa 192
AS - Asia 173
SA - Sud America 45
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 773
Nazione #
US - Stati Uniti d'America 344
SG - Singapore 110
IT - Italia 86
BR - Brasile 37
DE - Germania 37
CN - Cina 26
GB - Regno Unito 25
FI - Finlandia 12
CA - Canada 11
SE - Svezia 11
VN - Vietnam 9
HK - Hong Kong 8
NL - Olanda 6
RU - Federazione Russa 5
IN - India 4
TR - Turchia 4
CZ - Repubblica Ceca 3
MX - Messico 3
VE - Venezuela 3
AR - Argentina 2
AT - Austria 2
BD - Bangladesh 2
ID - Indonesia 2
PK - Pakistan 2
PL - Polonia 2
ZA - Sudafrica 2
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
EU - Europa 1
IQ - Iraq 1
JM - Giamaica 1
JO - Giordania 1
JP - Giappone 1
LB - Libano 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 773
Città #
Chandler 57
Singapore 55
Munich 35
Dallas 33
Chicago 24
London 19
Ashburn 18
Hefei 18
Santa Clara 17
Carbonia 12
Lawrence 12
Milan 11
Princeton 11
Turku 10
Hong Kong 8
The Dalles 7
Naples 6
Rome 6
Boardman 5
Wilmington 5
Ercolano 4
Los Angeles 4
Ottawa 4
São Paulo 4
Brooklyn 3
Catanzaro 3
Des Moines 3
Montreal 3
New York 3
Olomouc 3
Phoenix 3
Afragola 2
Charlotte 2
Cosenza 2
Genoa 2
Hanoi 2
Helsinki 2
Johannesburg 2
Lahore 2
Niterói 2
Porto Alegre 2
Reggio Calabria 2
San Nicola Manfredi 2
St Petersburg 2
Vienna 2
Warsaw 2
Alfenas 1
Alvorada 1
Amman 1
Ankara 1
Atlanta 1
Balıkesir 1
Bandar Seri Begawan 1
Bay City 1
Bay Shore 1
Beirut 1
Belo Horizonte 1
Benevento 1
Biên Hòa 1
Boston 1
Buffalo 1
Bắc Giang 1
Caicó 1
Campinas 1
Caracas 1
Caucaia 1
Chaguanas 1
Cleveland 1
Colton 1
Columbus 1
Concordia 1
Corona 1
Council Bluffs 1
Crestview 1
Curitiba 1
Darregueira 1
Denver 1
Florianópolis 1
Greensboro 1
Guadalajara 1
Haiphong 1
Hanover 1
Ho Chi Minh City 1
Hyderabad 1
Hòa Bình 1
Hải Dương 1
Irving 1
Itacaré 1
Itambaracá 1
Jakarta 1
Juquiá 1
Kensington 1
Kingston 1
Kolkata 1
Lajeado 1
Leicester 1
Lençóis Paulista 1
Limeira 1
Lisbon 1
Manaus 1
Totale 490
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 89
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer 64
Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade 57
Whole gene expression profiling shows a differential transcriptional response to CISPLATINUM in BRCA-1 defective versus BRCA1-reconstituted breast cancer cells 53
Case Report: Identification of a Novel Pathogenic Germline TP53 Variant in a Family With Li–Fraumeni Syndrome 52
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 51
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 49
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 48
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 44
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 42
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 42
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 40
Distinctive role of the systemic inflammatory profile in non-small-cell lung cancer younger and elderly patients treated with a pd-1 immune checkpoint blockade: A real-world retrospective multi-institutional analysis 39
Efficacy and safety of first-line checkpoint inhibitors-based treatments for non-oncogene-addicted non-small-cell lung cancer: a systematic review and meta-analysis 35
Possibility of identification and expression modality of bronchogenic carcinoma 30
Gut Microbiota Are a Novel Source of Biomarkers for Immunotherapy in Non-Small-Cell Lung Cancer (NSCLC) 26
Prognostic Role of Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte Ratio (LMR), Platelet-to-Lymphocyte Ratio (PLR) and Lymphocyte-to-C Reactive Protein Ratio (LCR) in Patients with Hepatocellular Carcinoma (HCC) undergoing Chemoembolizations (TACE) of the Liver: The Unexplored Corner Linking Tumor Microenvironment, Biomarkers and Interventional Radiology 24
Exercise therapy as treatment for oncologic disease after a diagnosis of early-stage cancer: effects on lifestyle 20
null 4
Totale 809
Categoria #
all - tutte 7.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202110 0 0 0 2 0 3 2 0 2 1 0 0
2021/202236 0 0 0 15 0 0 2 3 6 5 4 1
2022/2023156 27 8 10 8 18 14 2 10 23 16 13 7
2023/2024113 37 9 10 9 6 23 2 2 0 1 7 7
2024/2025320 26 6 8 4 23 31 8 7 45 7 69 86
2025/2026164 46 59 59 0 0 0 0 0 0 0 0 0
Totale 809